Sativa Investments 'at the forefront' of developing UK medical cannabis market

Geremy Thomas, founder and chief executive of Sativa Investments PLC (LON:SATI), caught up with Proactive London’s Andrew Scott to discuss the NEX-based medical cannabis investor’s trading and strategic update.

Sativa’s this week unveiled plans to become a first-mover seed-to-consumer business in the UK.

The firm’s taking its cue from Canada, which first approved the drug for medical use 18 years ago, and is now home to vertically integrated cannabis giants such as Canopy Growth (now listed in New York and worth around US$10bn).

Posted in Investors